Catherine Lutz, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1401 W Pawnee St, Cleveland, OK 74020 Phone: 918-358-2501 |
Champion Therapy Services Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 603 N C Ave, Cleveland, OK 74020 Phone: 918-358-8040 Fax: 918-358-8045 |
Elizabeth Edison Fielding, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 910 W Caddo St, Cleveland, OK 74020 Phone: 918-760-0321 Fax: 918-358-5230 |
Whitney Shea Poston-shannon, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1401 W Pawnee St, Cleveland, OK 74020 Phone: 918-358-2501 Fax: 918-358-3307 |
Kevin Roberts, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1401 W Pawnee St, Cleveland, OK 74020 Phone: 918-358-2501 |
News Archive
This study addresses depression and burn-out among a sample of psychiatrists collected at a professional congress. Within several constraints, the results indicate an high self-rated lifetime prevalence of depression of 41.6% among the sample. Also noteworthy is that a fifth (20.3%) of the sample showed evidence of acute depressive symptoms.
A new type of breast cancer treatment has shown encouraging activity as a first-line therapy in HER2-positive metastatic disease, researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
AFFiRiS AG will explore ProBioGen's proprietary Human Artificial Lymph Node Technology (HuALN) as analytical tool for its AFFITOME®-based vaccination concept. Under the contract with ProBioGen, AFFiRiS will evaluate the HuALN technology as a human organoid model to investigate drug-related effects in the context of the human immune system in order to select vaccine candidates best suited to be applied in humans.
A chemically-modified version of a mitochondrial toxin long used to control species of invasive fish in lakes has been found to selectively inhibit two "survival proteins" in cancer cells.
The National Institutes of Health has awarded $5.7M for a five-year, multicenter study, which will be the first in the U.S. to evaluate the long-term outcomes of medical treatment for transgender youth.
› Verified 4 days ago